Body Dysmorphic Disorder: Fluoxetine in Pediatric Body Dysmorphic Disorder

Contact name: Mary Walters

Phone: (401)-455-6466

Fax: (401)-455-6539

Email: mwalters@butler.org

Disorder: Body Dysmorphic Disorder

Geographic location: Providence, RI-area

Other keywords: OCD, anxiety disorders

Participant compensation: $50 for screening visit, $25 for each subsequent visit

Time commitment required: Weekly visits for first 7 weeks, biweekly thereafter. Screening visit is 3 hours long, each subsequent visit will be 40minutes-1 hour long

Drug trial: Yes

Recruitment end date (approximate): 3/31/06

Study criteria (i.e., age or gender requirements):
Medically healthy children and adolescents who are preoccupied with the way they look, often about an imagined flaw.

Exclusion criteria:
Individuals diagnosed with psychotic disorders or bipolar disorder, have substance abuse or dependence, need hospitalization, are undergoing cognitive behavioral therapy or are pregnant.

Brief description of study:
People with body dysmorphic disorder (BDD) worry about their appearance, thinking there's something wrong with how they look. BDD usually begins during childhood or adolescence but very little is known about what treatments help this age group. Research is greatly needed to answer this important question. We are studying the effectiveness of the medication fluoxetine for children and adolescents with BDD who qualify for our study. People who qualify will receive free study treatment and are paid for their participation.

Additional information:
This study is being done by BDD experts at Butler Hospital/Brown Medical School in Providence, Rhode Island (Dr. Katharine Phillips), Mount Sinai Medical center in New York City (Dr. Eric Hollander), and the University of Cincinnati School of Medicine in Cincinnati, Ohio (Drs. Brian McConville and Susan McElroy).